Prenetics Global (PRE) Cash from Investing Activities (2025 - 2026)

Prenetics Global (PRE) posted quarterly Cash from Investing Activities of $49.4 million for Q1 2026, up 11131.36% year-over-year from N/an in Q1 2025, and up 239.38% quarter-over-quarter from -$35.5 million in Q4 2025.

Prenetics Global (PRE) Cash from Investing Activities (2025 - 2026) Analysis & Trends

Prenetics Global (PRE) has reported Cash from Investing Activities for 2 consecutive years, with $49.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 11131.36% year-over-year to $49.4 million; the TTM figure through Mar 2026 stood at -$5.3 million (changed N/A YoY), while the FY2025 annual figure was -$35.7 million, down 192.61% from the prior year.
  • Cash from Investing Activities grew to $49.4 million in Q1 2026 per PRE's latest filing, from -$35.5 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $49.4 million in Q1 2026 and bottomed at -$35.5 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn 164.00 Mn
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn -10.15 Bn
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn -25.50 Mn
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn -77.00 Mn
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn -381.00 Mn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn -32.14 Mn
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn -122.00 Mn
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn -1.94 Mn
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn -134.00 Mn
10 Prenetics Global 306.55 Mn 200.52 Mn 23.28 Mn 49.42 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 49.42 Mn
Mar 31, 2026 49.42 Mn
Dec 31, 2025 -35.46 Mn
Dec 31, 2025 -35.46 Mn
Jun 30, 2025 -19.67 Mn
Jun 30, 2025 -19.67 Mn
Mar 31, 2025 440,000.00
Mar 31, 2025 440,000.00